IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q1 2015. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $12,787,000 | -14.9% | 443,691 | -5.4% | 0.23% | -10.1% |
Q1 2016 | $15,025,000 | -42.5% | 469,250 | -23.2% | 0.26% | -39.7% |
Q4 2015 | $26,124,000 | -2.9% | 610,940 | -20.0% | 0.43% | +0.2% |
Q3 2015 | $26,892,000 | -29.6% | 763,760 | -8.2% | 0.43% | -17.4% |
Q2 2015 | $38,194,000 | -22.9% | 831,740 | -21.3% | 0.52% | -13.7% |
Q1 2015 | $49,527,000 | +101.5% | 1,056,680 | +36.2% | 0.60% | +108.7% |
Q4 2014 | $24,574,000 | – | 775,700 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |